PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
C-Ray Therapeutics Receives Radiopharmaceutical Manufacturing Authorization under China's MAH Framework
CHENGDU, China , June 25, 2026 /PRNewswire/ -- On June 23, 2026 , C-Ray Therapeutics (Chengdu) Co., Ltd. ("C-Ray Therapeutics") completed on-site inspections conducted by a panel of experts ...
2026-06-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Dimora Medical has joined the NPIAP Corporate Advisory Council as an Honorary Member
NEW YORK , June 25, 2026 /PRNewswire/ -- Dimora Medical, a continuous innovator in high-end medical care supplies, has officially joined the National Pressure Injury Advisory Panel (NPIAP) as a corporate ...
2026-06-25T    Health Care/Hospital   Medical/Pharmaceuticals 
ATLATL and Samsung Bioepis Launch 'Samsung Bioepis Innovation Prize C-Lab Outside' to Accelerate Early-Stage Biotech Innovation Across Asia-Pacific
Applications Open June 25 for Early-Stage Biotech Companies Developing Next-Generation Therapeutics and Platform Technologies ...
2026-06-25T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region
ABU DHABI, UAE , June 25, 2026 /PRNewswire/ -- As healthcare systems worldwide seek more resilient and efficient pathways to deliver innovative medicines, the Department of Health – Abu Dhabi (DoH) has ...
2026-06-25T    Health Care/Hospital   Medical/Pharmaceuticals 
HKeyBio Debuts HKEY-ExE™ 1.0 to Address Preclinical Bottlenecks in EoE and EgE Drug Development
The EoE-centered framework supports disease modeling, multidimensional efficacy endpoints, type 2 biomarker analysis, and cross-indication translational research ...
2026-06-24T    Health Care/Hospital   Medical/Pharmaceuticals 
Metabolon Delivers Large-Scale Metabolomics Dataset to Genomics England's 100,000 Genomes Project to Advance Rare Disease Research
Dataset from more than 7,500 participants expands multiomic analysis in rare disease research by combining metabolomics with genomic and clinical data ...
2026-06-24T    Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Frost & Sullivan: Aileen.ai Receives the 2026 North American Transformational Innovation Leadership Recognition for Advancing Relationship-Based AI-Enabled Senior Care
The company's innovative AI health companion enhances continuity of care through scalable, relationship-based support for older adults ...
2026-06-24T    Computer/Electronics   Health Care/Hospital 
HKeyBio Launches NHP Fast-Tox Program for Accelerating Non-GLP NHP Safety Risk Screening
The program supports early tolerability assessment, PK/TK-linked safety evaluation, immune-related risk screening, and pre-GLP dose design for biologics and immunomodulatory drug programs ...
2026-06-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine
IMU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time. Waters Biosciences' technologies, ...
2026-06-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Tarek Samad appointed EVP, Head of Research & Development at Lundbeck
VALBY, Denmark , June 24, 2026 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced that Tarek Samad has been appointed Executive Vice President and Head of Research & Development (R&D) ...
2026-06-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.